 | AbCellera Biologics Inc. | |||
| NasdaqGS : ABCL || Location: Canada | ||||
$12.82+0.37 (+2.97%) |
1.98 M | 12.13 - 12.99 | ||
| Last Updated:08/19/2022 04:00 | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| July 29, 2022 | 19.143 M |
| July 15, 2022 | 19.230 M |
| June 30, 2022 | 19.196 M |
| June 15, 2022 | 12.266 M |
| May 31, 2022 | 10.768 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 03/31/2022 | 0.38 | 0.54 | 42.10% |
| 12/31/2021 | 0.19 | 0.19 | 0.00% |
| 09/30/2021 | -0.05 | -0.08 | -60.00% |
| 06/30/2021 | 0.08 | -0.01 | -112.50% |
| 03/31/2021 | 0.38 | 0.37 | -2.60% |
ABCL Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 285.139M | Shares Float | 207.099M |
| Short Float | 19.143M | Market Cap | 3709.66M |
| Institution ownership | 42.22% | Insider ownership | 28.762% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | 0.74 | Forward EPS | -0.41 |